跳至主要内容
临床试验/NCT06205303
NCT06205303已完成不适用

An Interventional Study to Improve Medication Adherence Using Patient Decision Aid Among Adults With Under-Replaced HypoThyroidism (IMPART): A Randomized Control Study

SingHealth Polyclinics1 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2024年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
236
试验地点
1
主要终点
Knowledge about thyroxine replacement

研究概览

简要总结

Background:

Although hypothyroidism is easily treated with levothyroxine (LT4) replacement, results from several studies indicate that people receiving LT4 replacement often have under- or over-replaced thyroid function. Poor medication adherence and factors interfering with thyroxine absorption and bioavailability may result in such under-replacement. Using the COM-B (Capability, Motivation, and Opportunity - Behavior) model, a health education intervention using patient decision aid (PDA), was developed for primary care physicians to educate individuals about thyroxine replacement. Besides imparting health literacy, PDAs provide greater comfort of the patients to participate in decision making. Intervention with the PDA aims to improve the medication adherence by increasing patients' knowledge about thyroxine replacement.

Specific aims: The primary aim is to determine effectiveness of PDA in improving the knowledge, medication adherence and quality of life of the under-replaced hypothyroid adults in a primary care setting. Secondary aims are to explore their understanding and acceptance on the PDA and to assess their perceived usability of this PDA.

Methodology: A randomised controlled trial will be conducted at SingHealth Polyclinics (SHP) using mixed-method study design to determine effectiveness of PDA. Patient participants will be randomly allocated in a 1:1 ratio to either the intervention or control group. A total of 236 (118 in each group) patient participants will be enrolled by simple randomization. Eligible patient must be of age ≥21 years years and have LT4 under-replacement with Thyroid stimulating hormone (TSH) >3.7 mIU/L within the last 6 months.

Relevance/significance of the study: Findings from the study may add evidence to the scientific knowledge of using PDA to improve medication adherence and recommend development of similar interventions for other chronic medical conditions.

详细描述

Patient decision aids (PDA) help people involved in decision making by providing information about the options and outcomes, and by clarifying their concerns. PDAs will help the patients to participate in decision making through SHARE approach (seeking patients' participation, helping them to explore and compare treatment options, assessing their values and preferences, reaching a decision with them and evaluating the patients' decision). Decision aids have the potential to improve adherence by enabling patient-doctor communication on treatment-related factors.

PDAs have been shown to improve medication adherence across different chronic diseases like osteoporosis and prevention of coronary heart diseases with aspirin. These aids provide patients with valuable information and support, helping them make informed choices about their treatment plans and fostering better adherence to prescribed medications. Decision Aids are available for managing hyperthyroidism caused by Grave's disease, but not for hypothyroidism. Addressing this gap could greatly empower patients with hypothyroidism to make well-informed choices about their treatment and improve their overall experience with managing this condition.

Intervention and theoretical framework According to the Capability, Motivation, and Opportunity - Behavior (COM-B) model, Capability, Motivation, and Opportunity are all referred to as "components" that influence behavior. Capability refers to the 'individual's psychological and physical capacity to engage in the activity concerned' while Opportunity refers to all those 'factors that lie outside the individual that make the behaviour possible or provoke it.' Motivation includes 'all those cognitive processes that motivate direct behavior including the habitual processes, emotional responding and analytical decision-making.' Earlier models to improve medication adherence generally highlighted the importance of doctor-patient communication and its impact on patient satisfaction, knowledge and ignorance as key determinants of medication adherence. However, studies on health behavior have constantly shown that merely providing information alone is not an effective strategy to influence behavior like adherence to medication. The COM-B model explicitly considers external resources like physical and social environment, which are typically not considered in other models like transtheoretical model of behavior change or health belief model. Jackson et al considered that COM-B model provided a more comprehensive description of adherence than other existing models, making it easier to identify appropriate interventions.

Study objectives The aim is to evaluate the acceptance, usability, understanding and effectiveness of a PDA developed for hypothyroid adults in improving their knowledge, beliefs, adherence and quality of life in patients with under-replaced hypothyroid status in primary care.

Primary objective is

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥21 years
  • Able to read and speak English
  • Active patient with hypothyroidism at SingHealth Polyclinics (SHP) {had minimum of 2 follow-up visits at the respective study site in the last 12 months}
  • TSH >3.70 milli-international units per liter (mIU/L)

排除标准

  • Euthyroid state (TSH 0.65-3.70 mIU/L)
  • LT4 over-replacement (TSH <0.65 mIU/L)
  • Individuals who are severely ill or with hearing impairment and mental disturbances
  • Pregnant women
  • Sick euthyroid syndrome

研究组 & 干预措施

intervention arm using PDA

Experimental

The intervention arm participants will watch the PDA which is estimated to take 10 minutes, after their consultation with the physician. The participants will be directed to a private room to watch the PDA.

干预措施: Patient Decision Aid (Video) (Other)

Control arm

No Intervention

The control arm participants will receive a thyroxine replacement pamphlet at their routine clinic appointment but will not attend the health education session using the PDA.

结局指标

主要结局

Knowledge about thyroxine replacement

时间窗: through study completion, an average of 8 weeks to 9 months

Change in the scores using knowledge on thyroxine replacement questionnaire; a newly developed knowledge questionnaire to access patients' understanding of thyroxine replacement comprising 16 questions scored from a scale of 0-5: 0 (Always), 1 (a few times a week), 2 (once a week or less), 3 (a few times a month), 4 (once a month or less) and 5 (Never). A higher score indicates better understanding.

Medication adherence

时间窗: through study completion, an average of 8 weeks to 9 months

Change in the scores using five-item Medication Adherence Report Scale (MARS-5); MARS-5 score was calculated by summing the numeric score (range 1-5) from each question for out of 25 (range 5-25). A higher score indicates better adherence.

Beliefs about medication

时间窗: through study completion, an average of 8 weeks to 9 months

Change in the scores using Beliefs About Medicines Questionnaire (BMQ). The BMQ is an 18-item questionnaire which consists of two components assessing patient's perceptions towards medications, BMQ-Specific and BMQ-General. The responses in both subscales are recorded on a five-point Likert scale. A higher score indicate stronger beliefs.

Health related Quality of life

时间窗: through study completion, an average of 8 weeks to 9 months

Change in the scores using the 5 Level EuroQol-5 Dimension (EQ-5D-5L) questionnaire; The EQ-5D-5L tool comprises five dimensions, each describing a different aspect of health: mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression. Each dimension has five response levels (no problems, slight problems, moderate problems, severe problems, unable to/extreme problems). The proportion of patients reporting each level of problem on each dimension of the EuroQol-5 Dimension (EQ-5D) will be determined through study completion and compared. EuroQol Visual Analogue Scale (EQ VAS) provides a quantitative measure of the patient's perception of their overall health. The EQ VAS records the respondent's overall current health on a vertical scale (0-100), where the endpoints are labelled '0-The worst health you can imagine' and '100-The best health you can imagine'.

次要结局

  • Usability of PDA(after the intervention up to 9 months)
  • Patients' understanding and acceptance(immediately after the intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kalaipriya Gunasekaran

Principal Investigator

SingHealth Polyclinics

研究点 (1)

Loading locations...

相似试验

Interventional Study to Improve Medication Adherence... | 临床试验